Natco Pharma

BSE: 524816 | NSE: NATCOPHARM
Natco Pharma (CIN: L24230TG1981PLC003201) operates in the Pharmaceuticals industry and has been listed in the stock market since 11th Apr 1995. It currents trades on NSE with symbol NATCOPHARM and on BSE with scrip code 524816.
The registered office of the company is Natco House, Road No 2, Banjara Hills,Hyderabad,Telangana,500033.

The management team of Natco Pharma is led by Mr. V C NANNAPANENI who is the Executive Director-Chairperson. Other members of the management team consist of Mr. RAJEEV NANNAPANENI (Designation:Executive Director), S V V N Appa Rao (Designation:Chief Financial Officer), Mr. P S R K PRASAD (Designation:Executive Director), Mr. D LINGA RAO (Designation:Executive Director), Mr. G. S. MURTHY (Designation:Non-Executive - Independent Director), Mr. D G PRASAD (Designation:Non-Executive - Independent Director), Mr. T.V. RAO (Designation:Non-Executive - Independent Director), Mr. DR M U R NAIDU (Designation:Non-Executive - Independent Director), Mrs. DR LEELA DIGUMARTI (Designation:Non-Executive - Independent Director), Mr. SRIDHAR SANKARARAMAN (Designation:Non-Executive - Non Independent Director), M Adinarayana (Designation:Company Secretary & Vice President (Legal & Corporate Affairs)), .

The price and other financial information of Natco Pharma is as below -

BSE 637 -3.65 (-0.57%)

BSE

637 -3.65 (-0.57%)
Volume: 6,132.00
M. Cap: 11,563.00
P/E: 23.27
Prev. Close: 640.65
Day
52 Wk

NSE

633.90 -8.15 (-1.27%)
Volume: 75,479.00
M. Cap: 11,563.00
P/E: 23.27
Prev. Close: 642.05
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 8,66,46,505 47.64
Foreign Institutions 3,99,76,085 21.98
General Public 2,77,88,784 15.28
NBFC and Mutual Funds 1,43,68,028 7.90
Others 74,94,555 4.12
Financial Institutions 31,74,853 1.75
ForeignPromoter 24,38,540 1.34
Total 18,18,87,350 100.01

NSE Trade Data

Trade Snapshot
VWAP 636.31
Face Value 2.00
Traded Volume (shares) 82,442.00
Traded Value (lacs) 524.59
Free Float Market Cap (Crs) 5,839.04
52 week high 738.10
52 week low 480.00
Lower Price Band 513.65
Upper Price Band 770.45
Security-wise Delivery Position
Quantity Traded 66,932.00
Deliverable Quantity (gross across client level) 33,969.00
% of Deliverable Quantity to Traded Quantity 50.75 %
Value at Risk (VaR in %)
Security VaR 9.50
Index VaR -
VAR Margin 9.50
Extreme Loss Rate 5.00
Adhoc Margin -
Applicable Margin Rate 14.50

Financial Data

Consolidated
Figures in crore 2019 2018 2017
Net Sales 2,094.50 2,184.80 2,020.20
Operating Profit 925.00 968.80 697.30
Other Income 130.20 40.40 13.90
Interest 19.30 15.40 18.50
Depreciation 81.00 66.20 54.40
Profit Before Tax 824.70 887.20 624.40
Tax 182.30 192.00 139.50
Profit After Tax 642.40 695.20 484.90
Share Capital 36.50 36.90 34.90
Reserves 3,452.50 3,035.30 1,614.40
Net Worth 3,489.00 3,072.20 1,649.30
Loans 458.10 206.40 244.50
Gross Block 1,696.10 1,407.60 1,158.70
Investments 168.60 76.50 32.20
Cash 279.50 183.70 35.80
Debtors 506.20 637.50 475.20
Net Working Capital 1,915.70 1,707.30 696.40
Operating Profit Margin (%) 44.16 44.34 34.52
Net Profit Margin (%) 30.67 31.82 24.00
Earning Per Share (Rs) 35.31 37.73 27.85
Dividend (%) 312.50 412.50 337.50
Dividend Payout 91.90 150.90 117.60
Standalone
Figures in crore 2019 2018 2017
Net Sales 1,986.30 2,091.30 1,958.00
Operating Profit 946.30 967.80 705.20
Other Income 129.80 39.40 13.20
Interest 18.80 14.70 17.50
Depreciation 80.10 65.50 53.60
Profit Before Tax 847.40 887.60 634.10
Tax 180.30 189.40 139.30
Profit After Tax 667.10 698.20 494.80
Share Capital 36.50 36.90 34.90
Reserves 3,526.70 3,088.50 1,664.80
Net Worth 3,563.20 3,125.40 1,699.70
Loans 456.30 206.20 243.50
Gross Block 1,678.20 1,399.60 1,151.00
Investments 244.40 149.60 94.80
Cash 262.70 172.10 25.10
Debtors 491.60 606.00 468.90
Net Working Capital 1,922.70 1,686.70 683.20
Operating Profit Margin (%) 47.64 46.28 36.02
Net Profit Margin (%) 33.59 33.39 25.27
Earning Per Share (Rs) 36.55 37.84 28.36
Dividend (%) 312.50 412.50 337.50
Dividend Payout 91.90 150.90 117.60
Dividend Declared (₹)
The company has declared dividend 19 times between 12 Nov 2007 and 24 Feb 2020, totaling Rs. 48.00 so far. The most recent dividend was declared on 24 Feb 2020 for Rs. 3.5.

Financial Data Graph

The peers of Natco Pharma are AUROPHARMA, IOLCP and AARTIDRUGS.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.